{"text": "rt AT_USER biotech partnering is a many-splendored thing URL $exel $bmy #cancer URL"}
{"text": "biotech partnering is a many-splendored thing URL $exel $bmy #cancer URL"}
{"text": "biotech partnering is a many-splendored thing URL $exel $bmy #cancer URL"}
{"text": "biotech partnering is a many-splendored thing URL $exel $bmy #cancer URL"}
{"text": "#biotechs scorching today, $ibb +3% --- i'm long $abbv $abt $bmy $gild $gsk $hqh $hql $lly $nvs $pfe $teva $thw $thq long-term #investments"}
{"text": "#bristolmyerssquibb once jilted, peninsula biotech snuggles again with its ex. read more: URL $bmy"}
{"text": "#bristolmyerssquibb once jilted, peninsula biotech snuggles again with its ex. read more: URL $bmy"}
{"text": "#privatetrader monday's #outcomes update $bp $bmy $v URL"}
{"text": "$prgo going down fast $myl $bmy $gild $vrx $endp not cheap enough try minus $8.00. not looking forward to tomorrow trades."}
{"text": "exelixis shares jump after team up with bristol-myers on cancer trials $exel $bmy AT_USER URL $xbi $ibb"}
{"text": "rt @ stockguy22 \"$exel also had news earlier - they did deals w/ roche &amp; $bmy + earnings move &amp; u get profit taking (not uncommon) bwagspor\u00a1\u00ad"}
{"text": "$exel also had news earlier - they did deals w/ roche &amp; $bmy + earnings move &amp; u get profit taking (not uncommon) AT_USER AT_USER"}
{"text": "#bristolmyerssquibb exelixis rockets on bristol, roche i-o ties following merck-incyte team. read more: URL $bmy"}
{"text": "#bristolmyerssquibb exelixis rockets on bristol, roche i-o ties following merck-incyte team. read more: URL $bmy"}
{"text": "rt AT_USER $exel announces new agreements for cancer drug development URL $bmy $rhhby"}
{"text": "rt AT_USER $exel announces new agreements for cancer drug development URL $bmy $rhhby"}
{"text": "biotechs scorching today, ibb up 3% $ibb $atra $ljpc $htgm $gild $amgn $biib $vrtx $bmy $lly URL"}
{"text": "$exel announces new agreements for cancer drug development URL $bmy $rhhby"}
{"text": "$bmy having issues at 57.00 going to feed this into the bot for weakness tomorrow. URL"}
{"text": "keytruda could be a major 2017 growth opportunity for merck &amp;amp; co. URL $mrk $lly $nvs $bmy"}
{"text": "rt AT_USER new features coming soon! free week demo: URL   #ascendtrader $spy $qqq  $amd $atvi $gdx $f $bmy $aa\u00a1\u00ad"}
{"text": "rt AT_USER new features coming soon! free week demo: URL   #ascendtrader $spy $qqq  $amd $atvi $gdx $f $bmy $aa\u00a1\u00ad"}
{"text": "new features coming soon! free week demo: URL   #ascendtrader $spy $qqq  $amd $atvi $gdx $f\u00a1\u00ad URL"}
{"text": "#privatetrader monday's #outcomes $htz $ions $tgt $bmy $v URL"}
{"text": "$bmy 19-jan-18 52.5 puts (tied to stock)  traded 4,000 for a total premium of $1,720,000. URL URL"}
{"text": "need help finding momentum stocks? URL URL $rgse $jah $clr $dis $mo $bmy $pot $apa $cnq $ccl"}
{"text": "attractive call overwrites: $lb calls more expensive than 99% of history, $bmy 93%, $dltr 93%, $swn 88%, $mdlz 85%, $uvxy 85%, $gps 84%"}
{"text": "should investors be interested in bristol-myers squibb in 2017? URL $bmy $gsk $myl $pfe"}
{"text": "is carl icahn losing his midas touch? URL $aig $arii $bmy  via AT_USER"}
{"text": "rt AT_USER $exel looking at combo approach; inks clinical deals with $bmy, $rhhby to test cabo w/ pd-1 opdivo and pd-l1 atezolizumab"}
{"text": "#bristolmyerssquibb bristolmyers squibb to take part in cowen and company 37th annual global... read more: URL $bmy"}
{"text": "rt AT_USER $exel looking at combo approach; inks clinical deals with $bmy, $rhhby to test cabo w/ pd-1 opdivo and pd-l1 atezolizumab"}
{"text": "#bristolmyerssquibb bristolmyers squibb to take part in cowen and company 37th annual global... read more: URL $bmy"}
{"text": "cowen's steve scala out with 38-page report detailing proprietary statistical analyses of #immuno-oncology trials: $azn, $bmy, $mrk and more"}
{"text": "exelixis rockets on bristol, roche ties following merck-incyte team $exel $bmy $rhhby $mrk $incy $hznp URL"}
{"text": "bristol-myers squibb company $bmy expected to post fy2017 earnings of $2.84 per share URL #acn"}
{"text": "horizon pharma dips on 2017 views despite \"nothing alarming\" in q4 $hznp $bmy URL"}
{"text": "#bristolmyerssquibb exelixis and bristolmyers squibb enter clinical collaboration for latest... read more: URL $bmy"}
{"text": "$bmy 48 puts buying activity expiring on 16th jun, vol 1000"}
{"text": "#bristolmyerssquibb bristol-myers up 20.5% since earnings report: can it continue? - februar... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristol-myers up 20.5% since earnings report: can it continue? - februar... read more: URL $bmy"}
{"text": "$cldx parent co was b/o by $bmy. could see $cldx buyout this year URL"}
{"text": "$cldx could we see a $bmy buyout soon?"}
{"text": "rt AT_USER $bmy and $exel plan to initiate p3 trial of opdivo+cabometyx+/-yervoy in rcc,p3 hcc and bladder to follow,concerned abo\u00a1\u00ad"}
{"text": "$exel looking at combo approach; inks clinical deals with $bmy, $rhhby to test cabo w/ pd-1 opdivo and pd-l1 atezolizumab"}
{"text": "#bristolmyerssquibb bristolmyers squibb expands international immunooncology network iion. read more: URL $bmy"}
{"text": "#bristolmyerssquibb exelixis to start new combo cancer trials with bristol-myers and roche. read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristolmyers squibb expands international immunooncology network iion wi... read more: URL $bmy"}
{"text": "#bristolmyerssquibb exelixis and bristolmyers squibb enter clinical collaboration for latest... read more: URL $bmy"}
{"text": "#bristolmyerssquibb exelixis to start new combo cancer trials with bristol-myers and roche. read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristolmyers squibb expands international immunooncology network iion. read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristolmyers squibb expands international immunooncology network iion wi... read more: URL $bmy"}
{"text": "$bmy bristol-myers up 20.5% since earnings report: can it continue? URL #stocks #stockmarket #investing #finance $qqq $f"}
{"text": "benzinga: is carl icahn losing his midas touch? not quite URL $iep $aig $bmy $fcx $lng $htz $hlf $xrx $nav"}
{"text": "is carl icahn losing his midas touch? not quite URL $iep $aig $bmy $fcx $lng $htz $hlf $xrx $nav"}
{"text": "fda oks intellipharmaceutics' generic metformin; shares ahead 40% premarket URL $ipci $bmy"}
{"text": "$exel, $bmy, $rhhby enter clinical partnerships aimed at checkpoint inhibitor combos URL"}
{"text": "$exel, $bmy, $rhhby enter clinical partnerships aimed at checkpoint inhibitor combos URL"}
{"text": "s&amp;p100 #stocks performance $gd $amgn $msft $nee $rtn $bmy $celg $cat $fdx $jnj $pcln $mdt $dis $agn $intc  more@ URL"}
{"text": "most active chx securities, february 21-24: $spy, $fxi, $xlf, $hyg, $iwm, $bmy. view full market data at URL"}
{"text": "$oncs immunopulse il-12 granted fast track status by #fda for mm following treatment on $mrk keytruda or $bmy opdivo URL"}
{"text": "out $bmy +2k"}
{"text": "bmy top news - feb 27th, 2017 $bmy URL"}
{"text": "pundits dismiss too easily that $pfe won't bid for $bmy / there is a good chance they will imho"}
{"text": "exelixis, bristol-myers mount pivotal study of cabo/opdivo combo for frontline #kidneycancer $exel $bmy - URL"}
{"text": "$bmy long 57.01"}
{"text": "snippet roundup: cyclacel's data dredge and bristol's activist investor URL $cycc $bmy $srpt $podd $mdt $hznp $jnj"}
{"text": "$bmy trying to break down trend. price above short term 20 dma and 50 dma but below 200 dma. first rt @ 57.21. URL"}
{"text": "#bristolmyerssquibb bristol-myers squibb to take part in cowen and company 37th annual globa... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristol-myers squibb to take part in cowen and company 37th annual globa... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristol-myers squibb to take part in cowen and company 37th annual globa... read more: URL $bmy"}
{"text": "attractive put selling pricing: $lb puts more expensive than 91% of history, $dltr 83%, $ftr 81%, $gps 81%, $swn 81%, $bmy 73%, $vale 73%"}
{"text": "here we go, big moves in i/o this week, $exel moving on deal with $bmy and $arry is next"}
{"text": "$bmy leaps keeping alive!"}
{"text": "rt AT_USER $exel and $bmy enter clinical collaboration for late-stage combination trial in first-line renal cell carcinoma"}
{"text": "rt AT_USER worst performing $spy stocks so far in 2017: $swn -15.6%, $sig -16.0%, $bmy -16.7%, $m -17.6%, $qcom -17.8%, $kss -19.6%\u00a1\u00ad"}
{"text": "$bmy $exel plan to collaborate on pivotal trials of cabo &amp; opdivo +/- yervoy in 1l rcc calls for add'l trials in hcc, other tumors"}
{"text": "rt AT_USER sold all 200 $bmy at $56.70. #zzporte AT_USER"}
{"text": "sold all 200 $bmy at $56.70. #zzporte AT_USER"}
{"text": "sold 200 shares $bmy @ $56.50 URL"}
{"text": "naked chicken clothed markets' #60 URL \u00a1\u00ad  $yum $tsla #spacex $hd $wmt $vz $yhoo $kraft $bmy\u00a1\u00ad URL"}
{"text": "AT_USER AT_USER AT_USER look at $bmy too"}
{"text": "$exel rolls into phiii combo trials matching cabo w/ $bmy opdivo; adds #checkpoint pact w/ roche URL #cancer #biotech"}
{"text": "#bristolmyerssquibb bristol-myers squibb expands international immuno-oncology network (ii-o... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristol-myers squibb expands international immuno-oncology network (ii-o... read more: URL $bmy"}
{"text": "marketcurrents: bristol-myers closes $1.5b debt offering URL $bmy"}
{"text": "#bristolmyerssquibb exelixis and bristol-myers squibb enter clinical collaboration for late-... read more: URL $bmy"}
{"text": "#bristolmyerssquibb exelixis and bristol-myers squibb enter clinical collaboration for late-... read more: URL $bmy"}
{"text": "$bmy bristol-myers squibb to take part in cowen and company 37th annual global health care conference... - URL"}
{"text": "bristol-myers closes $1.5b debt offering URL $bmy #sitifatimah #malaysia #financialplanning"}
{"text": "bristol-myers closes $1.5b debt offering URL $bmy"}
{"text": "bristol-myers closes $1.5b debt offering URL $bmy"}
{"text": "rt AT_USER $bmy and $exel plan to initiate p3 trial of opdivo+cabometyx+/-yervoy in rcc,p3 hcc and bladder to follow,concerned abo\u00a1\u00ad"}
{"text": "AT_USER sold 25% more $exel (sweet 450% lt gain, bot mid feb16) on this little bump (collaboration w $bmy &amp;roche\u00a1\u00ad URL"}
{"text": "rt AT_USER largest open interest increases among single stock options for 2/27 include $bac, $aapl, $jcp, $bmy, and $nvda."}
{"text": "rt AT_USER largest open interest increases among single stock options for 2/27 include $bac, $aapl, $jcp, $bmy, and $nvda."}
{"text": "largest open interest increases among single stock options for 2/27 include $bac, $aapl, $jcp, $bmy, and $nvda."}
{"text": "with $bmy a potential takeover target \u00a8c which #pharma firm is likely to strike a #megamerger deal? #merger #aquisition"}
{"text": "$bmy and $exel plan to initiate p3 trial of opdivo+cabometyx+/-yervoy in rcc,p3 hcc and bladder to follow,concerned about toxicity of combo?"}
{"text": "national planning corp buys 6,098 shares of bristol-myers squibb company $bmy URL"}
